Randomised trial comparing combinations of cyclophosphamide and cisplatin without or with doxorubicin or 4′-epi-doxorubicin in the treatment of advanced ovarian cancer

International Journal of Gynecology and Obstetrics

Volumn 27, Issue 2, 1988, Pages 199-204

  Hernadi Z ^a   Juhasz B ^a   Poka R ^a   Lampe L G ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Chemotherapy; Comparison of CP, CAP and CEP combinations; Ovarian cancer; Randomised trial

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN;

CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; CYCLOPHOSPHAMIDE; CYSTADENOCARCINOMA; DOXORUBICIN; EPIRUBICIN; FEMALE; HUMAN; MIDDLE AGE; OVARIAN NEOPLASMS; RANDOM ALLOCATION; TIME FACTORS;

EID: 0023684583     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-7292(88)90008-2     Document Type: Article

References (14)

1. Epirubicin in advanced breast cancer. The experience of the Milan Cancer Institute
2. Clinical spectrum of anthracycline antibiotic cardiotoxicity
3. Chemotherapy of ovarian cancer with adriamycin (ADM) and cis-platinum (DDP)
4. Experimental evaluation of anthracycline analogs
5. Effect of modifications in position 4 of the chromophore or in position 4′ of the aminosugar, on the antitumor activity and toxicity of daunorubicin and doxorubicin
6. Regression models and life tables
7. Toxicity and response criteria of the ECOG
8. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
9. Preliminary observations of the cardiotoxicity of 4′epidoxorubicin: evaluation by endomyocardial biopsy
10. DDP based combination chemotherapy for advanced ovarian carcinoma
11. A randomised comparison of 4′epi-doxorubicin and doxorubicin in advanced breast cancer